Definition, scope, and population heterogeneity
A senior sleep dataset links sleep signals, schedules, and symptoms in later life with cognition, cardiopulmonary health, mobility, medication, falls, caregiving, and long-term outcomes. Sources may include polysomnography, home sleep tests, actigraphy, wearable devices, mattress or radar sensors, diaries, questionnaires, electronic health records, and care logs. Each resource should report its actual age range and eligibility basis instead of assuming an unstated, universally applicable cutoff for “older adult.”
The same age does not imply the same health or living context. People living independently, with relatives, in assisted living or long-term care, or in hospital differ in sleep opportunity, care interruptions, sensor tolerance, and outcomes. The same is true across intact cognition, mild cognitive impairment, and dementia. A cohort restricted by sex, region, or disease can answer a bounded question but does not automatically represent all older people. Age-related differences in sleep are not themselves a disease, so documentation should distinguish expected variation, comorbidity, and measurement limitations.
Cohort structure, functional status, and change over time
Beyond age and demographic variables, a useful data dictionary may include living setting, activities of daily living, mobility and falls, cognition and mood, hearing and vision, pain, nocturia, major conditions, mobility or respiratory aids, daytime activity, and social schedules. Medication records should include generic name or class, dose, timing, and changes, with a distinction between an enrollment list and use on the recording night. Naps, time in bed, nighttime bed exits, care rounds, and unusual events also affect interpretation.
Longitudinal resources should represent people, visits, nights, devices, and outcome events separately, with an actual time attached to every measurement. A cognitive test, diagnosis, prescription, fall, or hospitalization may be months or years away from a sleep examination and is not contemporaneous merely because it appears in one table. Death, severe illness, institutionalization, inability to continue wearing a device, and withdrawal create informative attrition. Missing follow-up cannot be interpreted as improved sleep. Participant flow and reasons for inclusion at every visit should remain traceable.
Measurement modalities, settings, and synchronized context
Polysomnography may provide EEG, EOG, muscle activity, respiration, oxygen saturation, ECG, position, and limb movement. Actigraphy and wearables can observe multiple nights, while bedside or room sensors may estimate bed occupancy, breathing, or bed exits. Every modality needs device model, hardware and software version, placement, sampling rate, units, filters, timestamp definition, and valid intervals. Raw waveforms, derived heart rate, automated sleep stages, and night-level scores are different data layers and must be identified separately.
Setting changes the meaning of a signal. Caregiver entry, repositioning assistance, toileting, medication rounds, oxygen or positive-airway-pressure therapy, roommate activity, bed transfers, and hospital routines can alter a night record. Event logs should synchronize care and device events and address time zone, daylight-saving transitions, clock drift, and dates across midnight. Contactless sensors must distinguish the participant from caregivers; wearables need records of forgotten wear, charging, loosening, and skin discomfort. One laboratory night should not be treated as a person's long-term home schedule without qualification.
Labels, clinical linkage, and outcome definitions
Sleep stages and respiratory, arousal, and periodic limb-movement events should identify the scoring rules and version, required sensors, scorers, and treatment of unscorable intervals. EEG amplitude, fragmented sleep, abnormal EEG, or low mobility may complicate interpretation in some older adults, but arbitrary rule changes cannot be used to manufacture agreement. Prolonged immobility in actigraphy is especially prone to being labeled as sleep and should be checked against diaries, light, event markers, or synchronized references. Automated device stages are not technician-scored PSG labels.
Diagnoses, prescriptions, cognitive scales, falls, fractures, cardiovascular events, institutionalization, and death require a source, adjudication process, time window, and status. Self-report, caregiver report, billing codes, and clinically adjudicated events are distinct evidence layers. Analyses of sleep with cognitive or functional change must establish whether the sleep measure preceded the outcome and consider disease, pain, depression, medication, activity, and reverse causation. An observational association is not by itself a disease mechanism or a treatment effect.
Data quality, missingness, and representation
Low perfusion, tremor, restricted joint movement, quiet wakefulness in bed, fragile skin, cognitive difficulty, and device-operation barriers may affect signals or adherence. Quality flags should distinguish sensor failure, nonwear, quiet wake, care interruptions, algorithm rejection, and an entirely missing night. Valid duration should be reported by channel, person, and night. Filling with zeros or deleting low-quality intervals is not a substitute for transparent missing-data reporting. Quality thresholds should also be examined across device, site, and functional status so that the frailest participants are not systematically removed.
Community cohorts often favor people able to attend visits and operate devices, whereas institutional datasets reflect particular care workflows. Sex-restricted and disease-specific cohorts have additional sampling boundaries. Publishers should count those recruited, those offered sleep measurements, those with usable data, and those completing follow-up, then compare included and excluded groups. Age ceilings, cognitive status, disability, skin characteristics relevant to optical sensing, geography, socioeconomic circumstances, and digital access may all affect generalization. A large number of epochs or repeat nights is not a large number of independent participants.
Machine learning, causal analysis, and evaluation
Training, validation, and testing must be split by person. Repeat visits, neighboring windows, multimodal views, and augmented copies from the same individual belong in one partition. Institutional workflows and device models can leave strong signatures, so grouping by institution or leave-one-site-out testing may also be necessary. Normalization, imputation, quality selection, and thresholds should use training data only. External tests should cover different age ranges, sexes, functional and cognitive states, living settings, and devices, while reporting groups for whom the system produces no output.
Metrics must fit the use. Staging and event detection need class-level performance and agreement; sleep duration or bed-exit estimation needs bias and boundary error; alerting also needs missed events, false alarms per hour, and burden on caregivers. Systems that influence referral, fall alerts, or care priority should report errors near action thresholds and preserve human review. Causal studies should predefine exposure, outcome, time zero, confounders, and missing-data strategy while addressing time-varying factors and competing risks. Accurate prediction does not show that intervening on the predictor will improve the outcome.
Decision capacity, privacy governance, and clinical boundaries
The combination of sleep, cognition, medication, facility, nighttime movement, and long-term outcomes can make a person highly identifiable and may expose caregivers or co-residents. Releases should minimize direct and indirect identifiers, protect exact dates and rare combinations, use application-based or controlled access proportionate to risk, and document linkage, commercial training, retention, withdrawal, and export rules. Capacity to consent for a person with cognitive impairment requires assessment under applicable rules. Permission from a legally authorized representative is not unlimited authorization, and the participant's current wishes should still be respected.
Datasets can support research, device validation, and clinical decision support, but age or an algorithm output cannot independently diagnose insomnia, sleep apnea, dementia, or fall risk, nor convert a group association into personal treatment advice. A care-facing model requires validation in its target population, device, and setting; documented failure modes, escalation, and responsibility; and accessible processes for people with sensory, cognitive, or digital barriers. Persistent daytime sleepiness, signs of apnea, injury from dream enactment, or another important symptom warrants evaluation by a qualified healthcare professional.